The Manufacturers Life Insurance Company bought a new position in shares of Celestica, Inc. (NYSE:CLS – Free Report) (TSE:CLS) during the second quarter, HoldingsChannel reports. The fund bought 965,950 shares of the technology company’s stock, valued at approximately $351,717,000.
Several other institutional investors also recently modified their holdings of the stock. Renaissance Technologies LLC bought a new stake in shares of Celestica during the first quarter worth about $68,952,000. CIBC Asset Management Inc raised its holdings in Celestica by 7.7% in the 4th quarter. CIBC Asset Management Inc now owns 436,922 shares of the technology company’s stock valued at $129,499,000 after buying an additional 31,086 shares during the last quarter. Norges Bank acquired a new stake in Celestica during the 4th quarter worth approximately $456,511,000. Marietta Investment Partners LLC acquired a new stake in Celestica during the 4th quarter worth approximately $1,273,000. Finally, BW Gestao de Investimentos Ltda. boosted its position in Celestica by 29.9% during the 4th quarter. BW Gestao de Investimentos Ltda. now owns 31,179 shares of the technology company’s stock worth $9,217,000 after buying an additional 7,179 shares during the period. 67.38% of the stock is currently owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
Several equities analysts have issued reports on CLS shares. Susquehanna upped their price target on shares of Celestica from $460.00 to $510.00 and gave the company a “positive” rating in a research report on Wednesday, April 29th. JPMorgan Chase & Co. lifted their price target on shares of Celestica from $445.00 to $485.00 and gave the stock an “overweight” rating in a report on Wednesday, July 29th. UBS Group raised shares of Celestica from a “neutral” rating to a “buy” rating and boosted their price objective for the stock from $410.00 to $430.00 in a research note on Monday. TD Securities upgraded Celestica from a “hold” rating to a “buy” rating and set a $430.00 price objective for the company in a report on Wednesday, April 29th. Finally, Zacks Research upgraded Celestica from a “hold” rating to a “strong-buy” rating in a report on Friday, June 26th. One investment analyst has rated the stock with a Strong Buy rating, twenty-one have given a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Buy” and a consensus target price of $439.81.
Celestica Stock Performance
NYSE:CLS opened at $294.40 on Tuesday. The company has a market capitalization of $33.85 billion, a PE ratio of 30.60 and a beta of 2.06. The company has a 50 day simple moving average of $338.98 and a two-hundred day simple moving average of $335.49. The company has a debt-to-equity ratio of 0.32, a quick ratio of 0.68 and a current ratio of 1.23. Celestica, Inc. has a fifty-two week low of $183.66 and a fifty-two week high of $474.02.
Celestica (NYSE:CLS – Get Free Report) (TSE:CLS) last issued its quarterly earnings results on Monday, July 27th. The technology company reported $2.54 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.29 by $0.25. Celestica had a net margin of 7.16% and a return on equity of 39.96%. The firm had revenue of $4.68 billion for the quarter, compared to the consensus estimate of $4.30 billion. During the same quarter in the previous year, the company earned $1.39 EPS. The company’s revenue for the quarter was up 62.4% on a year-over-year basis. Celestica has set its FY 2026 guidance at 11.300-11.300 EPS and its Q3 2026 guidance at 2.880-3.080 EPS. Research analysts anticipate that Celestica, Inc. will post 10.15 earnings per share for the current year.
Insiders Place Their Bets
In other Celestica news, CFO Mandeep Chawla sold 17,000 shares of the company’s stock in a transaction on Monday, June 15th. The shares were sold at an average price of $399.65, for a total transaction of $6,794,050.00. Following the sale, the chief financial officer owned 82,444 shares of the company’s stock, valued at approximately $32,948,744.60. This represents a 17.10% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO Robert Mionis sold 98,453 shares of the company’s stock in a transaction on Tuesday, August 4th. The shares were sold at an average price of $368.99, for a total transaction of $36,328,172.47. The SEC filing for this sale provides additional information. Insiders have sold 356,553 shares of company stock valued at $135,238,444 in the last three months. 1.10% of the stock is owned by insiders.
About Celestica
Celestica Inc is a multinational electronics manufacturing services (EMS) company that provides design, engineering, manufacturing and supply chain solutions to original equipment manufacturers across a range of industries. Headquartered in Toronto, Ontario, Canada, Celestica works with customers to develop and produce complex electronic and electro-mechanical products, integrating activities from product design and prototyping through high-volume assembly, testing and final system integration.
The company’s service offering typically includes product engineering and design support, printed circuit board assembly, box-build and systems assembly, automated test and inspection, aftermarket repair and refurbishment, and end-to-end supply chain and logistics management.
Recommended Stories
- Five stocks we like better than Celestica
- Visa Just Put Hims & Hers in the Penalty Box—Here’s Why It Matters
- Treasury Yields Are Surging Again: 3 Stocks That Could Feel the Pain
- Snowflake Could Be Headed for New Highs Despite Insider Selling
- MongoDB Is Surging—And the Next Catalyst Is Almost Here
Want to see what other hedge funds are holding CLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Celestica, Inc. (NYSE:CLS – Free Report) (TSE:CLS).
Receive News & Ratings for Celestica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celestica and related companies with MarketBeat.com's FREE daily email newsletter.
